{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:19:08Z","timestamp":1790083148542,"version":"4.0.1"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2022]]},"DOI":"10.4103\/1673-5374.332123","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:51:21Z","timestamp":1639097481000},"page":"1633","source":"Crossref","is-referenced-by-count":19,"title":["Motor neuron replacement therapy for amyotrophic lateral sclerosis"],"prefix":"10.4103","volume":"17","author":[{"given":"Lingyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bochao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.332123-1","doi-asserted-by":"crossref","unstructured":"Abati E, Bresolin N, Comi GP, Corti S (2019a) Preconditioning and cellular engineering to increase the survival of transplanted neural stem cells for motor neuron disease therapy. Mol Neurobiol 56:3356-3367.","DOI":"10.1007\/s12035-018-1305-4"},{"key":"key-10.4103\/1673-5374.332123-2","doi-asserted-by":"crossref","unstructured":"Abati E, Bresolin N, Comi G, Corti S (2019b) Advances, challenges, and perspectives in translational stem cell therapy for amyotrophic lateral sclerosis. Mol Neurobiol 56:6703-6715.","DOI":"10.1007\/s12035-019-1554-x"},{"key":"key-10.4103\/1673-5374.332123-3","doi-asserted-by":"crossref","unstructured":"Alipour M, Nabavi SM, Arab L, Vosough M, Pakdaman H, Ehsani E, Shahpasand K (2019) Stem cell therapy in Alzheimer\u2019s disease: possible benefits and limiting drawbacks. Mol Biol Rep 46:1425-1446.","DOI":"10.1007\/s11033-018-4499-7"},{"key":"key-10.4103\/1673-5374.332123-4","doi-asserted-by":"crossref","unstructured":"Arbour D, Vande Velde C, Robitaille R (2017) New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction. J Physiol 595:647-661.","DOI":"10.1113\/JP270213"},{"key":"key-10.4103\/1673-5374.332123-5","doi-asserted-by":"crossref","unstructured":"Atassi N, Beghi E, Blanquer M, Boulis NM, Cantello R, Caponnetto C, Chio A, Dunnett SB, Feldman EL, Vescovi A, Mazzini L, attendees of the International Workshop on Progress in Stem Cells Research for AM (2016) Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? Cytotherapy 18:1471-1475.","DOI":"10.1016\/j.jcyt.2016.08.005"},{"key":"key-10.4103\/1673-5374.332123-6","doi-asserted-by":"crossref","unstructured":"Azuma K, Yamanaka S (2016) Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies. Regen Ther 4:36-47.","DOI":"10.1016\/j.reth.2016.01.009"},{"key":"key-10.4103\/1673-5374.332123-7","doi-asserted-by":"crossref","unstructured":"Baloh RH, Glass JD, Svendsen CN (2018) Stem cell transplantation for amyotrophic lateral sclerosis. Curr Opin Neurol 31:655-661.","DOI":"10.1097\/WCO.0000000000000598"},{"key":"key-10.4103\/1673-5374.332123-8","doi-asserted-by":"crossref","unstructured":"Ban H, Nishishita N, Fusaki N, Tabata T, Saeki K, Shikamura M, Takada N, Inoue M, Hasegawa M, Kawamata S, Nishikawa S (2011) Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci U S A 108:14234-14239.","DOI":"10.1073\/pnas.1103509108"},{"key":"key-10.4103\/1673-5374.332123-9","doi-asserted-by":"crossref","unstructured":"Berry JD, Cudkowicz ME, Windebank AJ, Staff NP, Owegi M, Nicholson K, McKenna-Yasek D, Levy YS, Abramov N, Kaspi H, Mehra M, Aricha R, Gothelf Y, Brown RH (2019) NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results. Neurology 93:e2294-2305.","DOI":"10.1212\/WNL.0000000000008620"},{"key":"key-10.4103\/1673-5374.332123-10","doi-asserted-by":"crossref","unstructured":"Bonafede R, Mariotti R (2017) ALS pathogenesis and therapeutic approaches: the role of mesenchymal stem cells and extracellular vesicles. Front Cell Neurosci 11:80.","DOI":"10.3389\/fncel.2017.00080"},{"key":"key-10.4103\/1673-5374.332123-11","doi-asserted-by":"crossref","unstructured":"Boulis NM, Federici T, Glass JD, Lunn JS, Sakowski SA, Feldman EL (2011) Translational stem cell therapy for amyotrophic lateral sclerosis. Nat Rev Neurol 8:172-176.","DOI":"10.1038\/nrneurol.2011.191"},{"key":"key-10.4103\/1673-5374.332123-12","doi-asserted-by":"crossref","unstructured":"Calabrese EJ, Calabrese V, Giordano J (2021) Demonstrated hormetic mechanisms putatively subserve riluzole-induced effects in neuroprotection against amyotrophic lateral sclerosis (ALS): Implications for research and clinical practice. Ageing Res Rev 67:101273.","DOI":"10.1016\/j.arr.2021.101273"},{"key":"key-10.4103\/1673-5374.332123-13","doi-asserted-by":"crossref","unstructured":"Chandrasekaran A, Avci HX, Leist M, Kobol\u00e1k J, Dinny\u00e9s A (2016) Astrocyte differentiation of human pluripotent stem cells: new tools for neurological disorder research. Front Cell Neurosci 10:215.","DOI":"10.3389\/fncel.2016.00215"},{"key":"key-10.4103\/1673-5374.332123-14","doi-asserted-by":"crossref","unstructured":"Chen H, Qian K, Du Z, Cao J, Petersen A, Liu H, Blackbourn Lisle W, Huang CL, Errigo A, Yin Y, Lu J, Ayala M, Zhang SC (2014) Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell 14:796-809.","DOI":"10.1016\/j.stem.2014.02.004"},{"key":"key-10.4103\/1673-5374.332123-15","doi-asserted-by":"crossref","unstructured":"Chen KS, Sakowski SA, Feldman EL (2016) Intraspinal stem cell transplantation for amyotrophic lateral sclerosis. Ann Neurol 79:342-353.","DOI":"10.1002\/ana.24584"},{"key":"key-10.4103\/1673-5374.332123-16","doi-asserted-by":"crossref","unstructured":"Deshpande DM, Kim YS, Martinez T, Carmen J, Dike S, Shats I, Rubin LL, Drummond J, Krishnan C, Hoke A, Maragakis N, Shefner J, Rothstein JD, Kerr DA (2006) Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 60:32-44.","DOI":"10.1002\/ana.20901"},{"key":"key-10.4103\/1673-5374.332123-17","doi-asserted-by":"crossref","unstructured":"Du ZW, Chen H, Liu H, Lu J, Qian K, Huang CL, Zhong X, Fan F, Zhang SC (2015) Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat Commun 6:6626.","DOI":"10.1038\/ncomms7626"},{"key":"key-10.4103\/1673-5374.332123-18","doi-asserted-by":"crossref","unstructured":"Ferrari D, Gelati M, Profico DC, Vescovi AL (2018) Human fetal neural stem cells for neurodegenerative disease treatment. Results Probl Cell Differ 66:307-329.","DOI":"10.1007\/978-3-319-93485-3_14"},{"key":"key-10.4103\/1673-5374.332123-19","doi-asserted-by":"crossref","unstructured":"Filipi T, Hermanova Z, Tureckova J, Vanatko O, Anderova AM (2020) Glial cells-the strategic targets in amyotrophic lateral sclerosis treatment. J Clin Med 9:261.","DOI":"10.3390\/jcm9010261"},{"key":"key-10.4103\/1673-5374.332123-20","doi-asserted-by":"crossref","unstructured":"Forostyak S, Forostyak O, Kwok JCF, Romanyuk N, Rehorova M, Kriska J, Dayanithi G, Raha-Chowdhury R, Jendelova P, Anderova M, Fawcett JW, Sykova E (2020) Transplantation of neural precursors derived from induced pluripotent cells preserve perineuronal nets and stimulate neural plasticity in ALS rats. Int J Mol Sci 21:9593.","DOI":"10.3390\/ijms21249593"},{"key":"key-10.4103\/1673-5374.332123-21","doi-asserted-by":"crossref","unstructured":"Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85:348-362.","DOI":"10.2183\/pjab.85.348"},{"key":"key-10.4103\/1673-5374.332123-22","doi-asserted-by":"crossref","unstructured":"Glass JD, Boulis NM, Johe K, Rutkove SB, Federici T, Polak M, Kelly C, Feldman EL (2012) Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells 30:1144-1151.","DOI":"10.1002\/stem.1079"},{"key":"key-10.4103\/1673-5374.332123-23","doi-asserted-by":"crossref","unstructured":"Glass JD, Hertzberg VS, Boulis NM, Riley J, Federici T, Polak M, Bordeau J, Fournier C, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges LF, Rutkove SB, Duell J, Patil PG, Goutman SA, Feldman EL (2016) Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials. Neurology 87:392-400.","DOI":"10.1212\/WNL.0000000000002889"},{"key":"key-10.4103\/1673-5374.332123-24","doi-asserted-by":"crossref","unstructured":"Glicksman MA (2018) Induced pluripotent stem cells: the most versatile source for stem cell therapy. Clin Ther 40:1060-1065.","DOI":"10.1016\/j.clinthera.2018.06.004"},{"key":"key-10.4103\/1673-5374.332123-25","doi-asserted-by":"crossref","unstructured":"Goutman SA, Savelieff MG, Sakowski SA, Feldman EL (2019) Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials. Expert Opin Investig Drugs 28:525-543.","DOI":"10.1080\/13543784.2019.1627324"},{"key":"key-10.4103\/1673-5374.332123-26","doi-asserted-by":"crossref","unstructured":"Gugliandolo A, Bramanti P, Mazzon E (2019) Mesenchymal stem cells: a potential therapeutic approach for amyotrophic lateral sclerosis? Stem Cells Int 2019:3675627.","DOI":"10.1155\/2019\/3675627"},{"key":"key-10.4103\/1673-5374.332123-27","doi-asserted-by":"crossref","unstructured":"Guo X, Johe K, Molnar P, Davis H, Hickman J (2010) Characterization of a human fetal spinal cord stem cell line, NSI-566RSC, and its induction to functional motoneurons. J Tissue Eng Regen Med 4:181-193.","DOI":"10.1002\/term.223"},{"key":"key-10.4103\/1673-5374.332123-28","doi-asserted-by":"crossref","unstructured":"Hamada A, Akagi E, Yamasaki S, Nakatao H, Obayashi F, Ohtaka M, Nishimura K, Nakanishi M, Toratani S, Okamoto T (2020) Induction of integration-free human-induced pluripotent stem cells under serum- and feeder-free conditions. In Vitro Cell Dev Biol Anim 56:85-95.","DOI":"10.1007\/s11626-019-00412-w"},{"key":"key-10.4103\/1673-5374.332123-29","doi-asserted-by":"crossref","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071.","DOI":"10.1038\/nrdp.2017.71"},{"key":"key-10.4103\/1673-5374.332123-30","doi-asserted-by":"crossref","unstructured":"Harper JM, Krishnan C, Darman JS, Deshpande DM, Peck S, Shats I, Backovic S, Rothstein JD, Kerr DA (2004) Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proc Natl Acad Sci U S A 101:7123-7128.","DOI":"10.1073\/pnas.0401103101"},{"key":"key-10.4103\/1673-5374.332123-31","doi-asserted-by":"crossref","unstructured":"Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, DeGennaro LJ, Cleveland DW, Rothstein JD (2002) Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A 99:1604-1609.","DOI":"10.1073\/pnas.032539299"},{"key":"key-10.4103\/1673-5374.332123-32","doi-asserted-by":"crossref","unstructured":"Ilary Allodi JN, Julio Aguila Benitez, Christoph Schweingruber, Andrea Fuchs, Gillian Bonvicini, Ming Cao, Ole Kiehn, Eva Hedlund (2016) Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat Neurosci 19:542-553.","DOI":"10.1038\/nn.4273"},{"key":"key-10.4103\/1673-5374.332123-33","doi-asserted-by":"crossref","unstructured":"Isogai S, Yamamoto N, Hiramatsu N, Goto Y, Hayashi M, Kondo M, Imaizumi K (2018) Preparation of induced pluripotent stem cells using human peripheral blood monocytes. Cell Reprogram 20:347-355.","DOI":"10.1089\/cell.2018.0024"},{"key":"key-10.4103\/1673-5374.332123-34","doi-asserted-by":"crossref","unstructured":"Izrael M, Slutsky SG, Admoni T, Cohen L, Granit A, Hasson A, Itskovitz-Eldor J, Krush Paker L, Kuperstein G, Lavon N, Yehezkel Ionescu S, Solmesky LJ, Zaguri R, Zhuravlev A, Volman E, Chebath J, Revel M (2018) Safety and efficacy of human embryonic stem cell-derived astrocytes following intrathecal transplantation in SOD1(G93A) and NSG animal models. Stem Cell Res Ther 9:152.","DOI":"10.1186\/s13287-018-0890-5"},{"key":"key-10.4103\/1673-5374.332123-35","doi-asserted-by":"crossref","unstructured":"Izrael M, Slutsky SG, Revel M (2020) Rising stars: astrocytes as a therapeutic target for ALS disease. Front Neurosci 14:824.","DOI":"10.3389\/fnins.2020.00824"},{"key":"key-10.4103\/1673-5374.332123-36","doi-asserted-by":"crossref","unstructured":"Jackson C, Heiman-Patterson T, Kittrell P, Baranovsky T, McAnanama G, Bower L, Agnese W, Martin M (2019) Radicava (edaravone) for amyotrophic lateral sclerosis: US experience at 1 year after launch. Amyotroph Lateral Scler Frontotemporal Degener 20:605-610.","DOI":"10.1080\/21678421.2019.1645858"},{"key":"key-10.4103\/1673-5374.332123-37","doi-asserted-by":"crossref","unstructured":"Jang SE, Qiu L, Chan LL, Tan EK, Zeng L (2020) Current status of stem cell-derived therapies for Parkinson\u2019s disease: from cell assessment and imaging modalities to clinical trials. Front Neurosci 14:558532.","DOI":"10.3389\/fnins.2020.558532"},{"key":"key-10.4103\/1673-5374.332123-38","doi-asserted-by":"crossref","unstructured":"Klontzas ME, Kakkos GA, Papadakis GZ, Marias K, Karantanas AH (2021) Advanced clinical imaging for the evaluation of stem cell based therapies. Expert Opin Biol Ther:1-12.","DOI":"10.1080\/14712598.2021.1890711"},{"key":"key-10.4103\/1673-5374.332123-39","doi-asserted-by":"crossref","unstructured":"Kondo T, Funayama M, Tsukita K, Hotta A, Yasuda A, Nori S, Kaneko S, Nakamura M, Takahashi R, Okano H, Yamanaka S, Inoue H (2014) Focal transplantation of human iPSC-derived glial-rich neural progenitors improves lifespan of ALS mice. Stem Cell Reports 3:242-249.","DOI":"10.1016\/j.stemcr.2014.05.017"},{"key":"key-10.4103\/1673-5374.332123-40","doi-asserted-by":"crossref","unstructured":"Lepore AC, Rauck B, Dejea C, Pardo AC, Rao MS, Rothstein JD, Maragakis NJ (2008) Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 11:1294-1301.","DOI":"10.1038\/nn.2210"},{"key":"key-10.4103\/1673-5374.332123-41","doi-asserted-by":"crossref","unstructured":"Lepore AC, O\u2019Donnell J, Kim AS, Williams T, Tuteja A, Rao MS, Kelley LL, Campanelli JT, Maragakis NJ (2011) Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One 6:e25968.","DOI":"10.1371\/journal.pone.0025968"},{"key":"key-10.4103\/1673-5374.332123-42","doi-asserted-by":"crossref","unstructured":"Li M, Liu F, Jiang H, Lee TS, Tang S (2017) Long-term two-photon imaging in awake macaque monkey. Neuron 93:1049-1057.","DOI":"10.1016\/j.neuron.2017.01.027"},{"key":"key-10.4103\/1673-5374.332123-43","doi-asserted-by":"crossref","unstructured":"Li X, Hacker M (2017) Molecular imaging in stem cell-based therapies of cardiac diseases. Adv Drug Deliv Rev 120:71-88.","DOI":"10.1016\/j.addr.2017.07.012"},{"key":"key-10.4103\/1673-5374.332123-44","doi-asserted-by":"crossref","unstructured":"Loh YH, Agarwal S, Park IH, Urbach A, Huo H, Heffner GC, Kim K, Miller JD, Ng K, Daley GQ (2009) Generation of induced pluripotent stem cells from human blood. Blood 113:5476-5479.","DOI":"10.1182\/blood-2009-02-204800"},{"key":"key-10.4103\/1673-5374.332123-45","doi-asserted-by":"crossref","unstructured":"Lopez-Gonzalez R, Kunckles P, Velasco I (2009) Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells. Cell Transplant 18:1171-1181.","DOI":"10.3727\/096368909X12483162197123"},{"key":"key-10.4103\/1673-5374.332123-46","doi-asserted-by":"crossref","unstructured":"Lou JS, Moore D, Gordon PH, Miller R (2010) Correlates of quality of life in ALS: Lessons from the minocycline study. Amyotroph Lateral Scler 11:116-121.","DOI":"10.3109\/17482960902918719"},{"key":"key-10.4103\/1673-5374.332123-47","doi-asserted-by":"crossref","unstructured":"Lu P, Ceto S, Wang Y, Graham L, Wu D, Kumamaru H, Staufenberg E, Tuszynski MH (2017) Prolonged human neural stem cell maturation supports recovery in injured rodent CNS. J Clin Invest 127:3287-3299.","DOI":"10.1172\/JCI92955"},{"key":"key-10.4103\/1673-5374.332123-48","doi-asserted-by":"crossref","unstructured":"Lu P, Wang Y, Graham L, McHale K, Gao M, Wu D, Brock J, Blesch A, Rosenzweig ES, Havton LA, Zheng B, Conner JM, Marsala M, Tuszynski MH (2012) Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 150:1264-1273.","DOI":"10.1016\/j.cell.2012.08.020"},{"key":"key-10.4103\/1673-5374.332123-49","doi-asserted-by":"crossref","unstructured":"Lu P, Woodruff G, Wang Y, Graham L, Hunt M, Wu D, Boehle E, Ahmad R, Poplawski G, Brock J, Goldstein LS, Tuszynski MH (2014) Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury. Neuron 83:789-796.","DOI":"10.1016\/j.neuron.2014.07.014"},{"key":"key-10.4103\/1673-5374.332123-50","doi-asserted-by":"crossref","unstructured":"Lunn JS, Sakowski SA, Feldman EL (2014) Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future. Stem Cells 32:1099-1109.","DOI":"10.1002\/stem.1628"},{"key":"key-10.4103\/1673-5374.332123-51","doi-asserted-by":"crossref","unstructured":"Lyman WD, Tricoche M, Hatch WC, Kress Y, Chiu FC, Rashbaum WK (1991) Human fetal central nervous system organotypic cultures. Brain Res Dev Brain Res 60:155-160.","DOI":"10.1016\/0165-3806(91)90044-J"},{"key":"key-10.4103\/1673-5374.332123-52","doi-asserted-by":"crossref","unstructured":"Malik N, Rao MS (2013) A review of the methods for human iPSC derivation. Methods Mol Biol 997:23-33.","DOI":"10.1007\/978-1-62703-348-0_3"},{"key":"key-10.4103\/1673-5374.332123-53","doi-asserted-by":"crossref","unstructured":"Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C, Daimon T, Fujihara M, Akimaru H, Sakai N, Shibata Y, Terada M, Nomiya Y, Tanishima S, Nakamura M, Kamao H, Sugita S, Onishi A, Ito T, Fujita K, Kawamata S, et al. (2017) Autologous induced stem-cell-derived retinal cells for macular degeneration. N Engl J Med 376:1038-1046.","DOI":"10.1056\/NEJMoa1608368"},{"key":"key-10.4103\/1673-5374.332123-54","doi-asserted-by":"crossref","unstructured":"Mazzini L, Gelati M, Profico DC, Sgaravizzi G, Projetti Pensi M, Muzi G, Ricciolini C, Rota Nodari L, Carletti S, Giorgi C, Spera C, Domenico F, Bersano E, Petruzzelli F, Cisari C, Maglione A, Sarnelli MF, Stecco A, Querin G, Masiero S, et al. (2015) Human neural stem cell transplantation in ALS: initial results from a phase I trial. J Transl Med 13:17.","DOI":"10.1186\/s12967-014-0371-2"},{"key":"key-10.4103\/1673-5374.332123-55","doi-asserted-by":"crossref","unstructured":"Mignani S, Majoral JP, Desaphy JF, Lentini G (2020) From riluzole to dexpramipexole via substituted-benzothiazole derivatives for amyotrophic lateral sclerosis disease treatment: case studies. Molecules 25:3320.","DOI":"10.3390\/molecules25153320"},{"key":"key-10.4103\/1673-5374.332123-56","doi-asserted-by":"crossref","unstructured":"Morizane A (2019) Cell therapy for Parkinson\u2019s disease with induced pluripotent stem cells. Rinsho Shinkeigaku 59:119-124.","DOI":"10.5692\/clinicalneurol.cn-001235"},{"key":"key-10.4103\/1673-5374.332123-57","doi-asserted-by":"crossref","unstructured":"Moshayedi P, Nih LR, Llorente IL, Berg AR, Cinkornpumin J, Lowry WE, Segura T, Carmichael ST (2016) Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain. Biomaterials 105:145-155.","DOI":"10.1016\/j.biomaterials.2016.07.028"},{"key":"key-10.4103\/1673-5374.332123-58","doi-asserted-by":"crossref","unstructured":"Nichols NL, Gowing G, Satriotomo I, Nashold LJ, Dale EA, Suzuki M, Avalos P, Mulcrone PL, McHugh J, Svendsen CN, Mitchell GS (2013) Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis. Am J Respir Crit Care Med 187:535-542.","DOI":"10.1164\/rccm.201206-1072OC"},{"key":"key-10.4103\/1673-5374.332123-59","doi-asserted-by":"crossref","unstructured":"Norris SP, Likanje MN, Andrews JA (2020) Amyotrophic lateral sclerosis: update on clinical management. Curr Opin Neurol 33:641-648.","DOI":"10.1097\/WCO.0000000000000864"},{"key":"key-10.4103\/1673-5374.332123-60","doi-asserted-by":"crossref","unstructured":"Nygren LG, Olson L, Seiger A (1977) Mnoaminergic reinnervation of the transected spinal cord by homologous fetal brain grafts. Brain Res 129:227-235.","DOI":"10.1016\/0006-8993(77)90003-8"},{"key":"key-10.4103\/1673-5374.332123-61","doi-asserted-by":"crossref","unstructured":"Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, Nori S, Ikeda E, Yamanaka S, Miura K (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112:523-533.","DOI":"10.1161\/CIRCRESAHA.111.256149"},{"key":"key-10.4103\/1673-5374.332123-62","doi-asserted-by":"crossref","unstructured":"Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451:141-146.","DOI":"10.1038\/nature06534"},{"key":"key-10.4103\/1673-5374.332123-63","doi-asserted-by":"crossref","unstructured":"Patel U, Bernstein JJ (1983) Growth, differentiation, and viability of fetal rat cortical and spinal cord implants into adult rat spinal cord. J Neurosci Res 9:303-310.","DOI":"10.1002\/jnr.490090307"},{"key":"key-10.4103\/1673-5374.332123-64","doi-asserted-by":"crossref","unstructured":"Pehar M, Harlan BA, Killoy KM, Vargas MR (2017) Role and therapeutic potential of astrocytes in amyotrophic lateral sclerosis. Curr Pharm Des 23:5010-5021.","DOI":"10.2174\/1381612823666170622095802"},{"key":"key-10.4103\/1673-5374.332123-65","doi-asserted-by":"crossref","unstructured":"Petrou P, Gothelf Y, Argov Z, Gotkine M, Levy YS, Kassis I, Vaknin-Dembinsky A, Ben-Hur T, Offen D, Abramsky O, Melamed E, Karussis D (2016) Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1\/2 and 2a clinical trials. JAMA Neurol 73:337-344.","DOI":"10.1001\/jamaneurol.2015.4321"},{"key":"key-10.4103\/1673-5374.332123-66","doi-asserted-by":"crossref","unstructured":"Piao J, Zabierowski S, Dubose BN, Hill EJ, Navare M, Claros N, Rosen S, Ramnarine K, Horn C, Fredrickson C, Wong K, Safford B, Kriks S, El Maarouf A, Rutishauser U, Henchcliffe C, Wang Y, Riviere I, Mann S, Bermudez V, et al. (2021) Preclinical efficacy and safety of a human embryonic stem cell-derived midbrain dopamine progenitor product, MSK-DA01. Cell Stem Cell 28:217-229.","DOI":"10.1016\/j.stem.2021.01.004"},{"key":"key-10.4103\/1673-5374.332123-67","doi-asserted-by":"crossref","unstructured":"Popescu IR, Nicaise C, Liu S, Bisch G, Knippenberg S, Daubie V, Bohl D, Pochet R (2013) Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis. Stem Cells Transl Med 2:167-174.","DOI":"10.5966\/sctm.2012-0042"},{"key":"key-10.4103\/1673-5374.332123-68","doi-asserted-by":"crossref","unstructured":"Poplawski GHD, Lie R, Hunt M, Kumamaru H, Kawaguchi R, Lu P, Schafer MKE, Woodruff G, Robinson J, Canete P, Dulin JN, Geoffroy CG, Menzel L, Zheng B, Coppola G, Tuszynski MH (2018) Adult rat myelin enhances axonal outgrowth from neural stem cells. Sci Transl Med 10:eaal2563.","DOI":"10.1126\/scitranslmed.aal2563"},{"key":"key-10.4103\/1673-5374.332123-69","doi-asserted-by":"crossref","unstructured":"Robinton DA, Daley GQ (2012) The promise of induced pluripotent stem cells in research and therapy. Nature 481:295-305.","DOI":"10.1038\/nature10761"},{"key":"key-10.4103\/1673-5374.332123-70","doi-asserted-by":"crossref","unstructured":"Rodrigues MC, Sanberg PR, Cruz LE, Garbuzova-Davis S (2014) The innate and adaptive immunological aspects in neurodegenerative diseases. J Neuroimmunol 269:1-8.","DOI":"10.1016\/j.jneuroim.2013.09.020"},{"key":"key-10.4103\/1673-5374.332123-71","doi-asserted-by":"crossref","unstructured":"Rosati J, Ferrari D, Altieri F, Tardivo S, Ricciolini C, Fusilli C, Zalfa C, Profico DC, Pinos F, Bernardini L, Torres B, Manni I, Piaggio G, Binda E, Copetti M, Lamorte G, Mazza T, Carella M, Gelati M, Valente EM, et al. (2018) Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies. Cell Death Dis 9:937.","DOI":"10.1038\/s41419-018-0990-2"},{"key":"key-10.4103\/1673-5374.332123-72","doi-asserted-by":"crossref","unstructured":"Rostalski H, Leskel\u00e4 S, Huber N, Katisko K, Cajanus A, Solje E, Marttinen M, Natunen T, Remes AM, Hiltunen M, Haapasalo A (2019) Astrocytes and microglia as potential contributors to the pathogenesis of C9orf72 repeat expansion-associated FTLD and ALS. Front Neurosci 13:486.","DOI":"10.3389\/fnins.2019.00486"},{"key":"key-10.4103\/1673-5374.332123-73","doi-asserted-by":"crossref","unstructured":"Sareen D, Gowing G, Sahabian A, Staggenborg K, Paradis R, Avalos P, Latter J, Ornelas L, Garcia L, Svendsen CN (2014) Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol 522:2707-2728.","DOI":"10.1002\/cne.23578"},{"key":"key-10.4103\/1673-5374.332123-74","doi-asserted-by":"crossref","unstructured":"Shihabuddin LS, Palmer TD, Gage FH (1999) The search for neural progenitor cells: prospects for the therapy of neurodegenerative disease. Mol Med Today 5:474-480.","DOI":"10.1016\/S1357-4310(99)01596-8"},{"key":"key-10.4103\/1673-5374.332123-75","doi-asserted-by":"crossref","unstructured":"Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K (2008) Induced pluripotent stem cells generated without viral integration. Science 322:945-949.","DOI":"10.1126\/science.1162494"},{"key":"key-10.4103\/1673-5374.332123-76","doi-asserted-by":"crossref","unstructured":"Suzuki M, McHugh J, Tork C, Shelley B, Klein SM, Aebischer P, Svendsen CN (2007) GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One 2:e689.","DOI":"10.1371\/journal.pone.0000689"},{"key":"key-10.4103\/1673-5374.332123-77","doi-asserted-by":"crossref","unstructured":"Takahashi J (2021) Clinical trial for Parkinson\u2019s disease gets a green light in the US. Cell Stem Cell 28:182-183.","DOI":"10.1016\/j.stem.2021.01.013"},{"key":"key-10.4103\/1673-5374.332123-78","doi-asserted-by":"crossref","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.","DOI":"10.1016\/j.cell.2007.11.019"},{"key":"key-10.4103\/1673-5374.332123-79","doi-asserted-by":"crossref","unstructured":"Tang BL (2017) The use of mesenchymal stem cells (MSCs) for amyotrophic lateral sclerosis (ALS) therapy\u2013a perspective on cell biological mechanisms. Rev Neurosci 28:725-738.","DOI":"10.1515\/revneuro-2017-0018"},{"key":"key-10.4103\/1673-5374.332123-80","doi-asserted-by":"crossref","unstructured":"Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA (2005) Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366:2019-2025.","DOI":"10.1016\/S0140-6736(05)67813-0"},{"key":"key-10.4103\/1673-5374.332123-81","doi-asserted-by":"crossref","unstructured":"Thomsen GM, Avalos P, Ma AA, Alkaslasi M, Cho N, Wyss L, Vit JP, Godoy M, Suezaki P, Shelest O, Bankiewicz KS, Svendsen CN (2018) Transplantation of neural progenitor cells expressing glial cell line-derived neurotrophic factor into the motor cortex as a strategy to treat amyotrophic lateral sclerosis. Stem Cells 36:1122-1131.","DOI":"10.1002\/stem.2825"},{"key":"key-10.4103\/1673-5374.332123-82","doi-asserted-by":"crossref","unstructured":"van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH (2017) Amyotrophic lateral sclerosis. Lancet 390:2084-2098.","DOI":"10.1016\/S0140-6736(17)31287-4"},{"key":"key-10.4103\/1673-5374.332123-83","doi-asserted-by":"crossref","unstructured":"Wang J, Hu WW, Jiang Z, Feng MJ (2020) Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors. World J Stem Cells 12:323-338.","DOI":"10.4252\/wjsc.v12.i5.323"},{"key":"key-10.4103\/1673-5374.332123-84","doi-asserted-by":"crossref","unstructured":"Wu P, Tarasenko YI, Gu Y, Huang LY, Coggeshall RE, Yu Y (2002) Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat Neurosci 5:1271-1278.","DOI":"10.1038\/nn974"},{"key":"key-10.4103\/1673-5374.332123-85","doi-asserted-by":"crossref","unstructured":"Yamanaka S (2012) Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10:678-684.","DOI":"10.1016\/j.stem.2012.05.005"},{"key":"key-10.4103\/1673-5374.332123-86","doi-asserted-by":"crossref","unstructured":"Yamanaka S (2020) Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell 27:523-531.","DOI":"10.1016\/j.stem.2020.09.014"},{"key":"key-10.4103\/1673-5374.332123-87","doi-asserted-by":"crossref","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin, II, Thomson JA (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.","DOI":"10.1126\/science.1151526"},{"key":"key-10.4103\/1673-5374.332123-88","doi-asserted-by":"crossref","unstructured":"Yuan Y, Tang X, Bai YF, Wang S, An J, Wu Y, Xu ZD, Zhang YA, Chen Z (2018) Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson\u2019s disease model. Theranostics 8:4679-4694.","DOI":"10.7150\/thno.26643"},{"key":"key-10.4103\/1673-5374.332123-89","doi-asserted-by":"crossref","unstructured":"Zalfa C, Rota Nodari L, Vacchi E, Gelati M, Profico D, Boido M, Binda E, De Filippis L, Copetti M, Garlatti V, Daniele P, Rosati J, De Luca A, Pinos F, Cajola L, Visioli A, Mazzini L, Vercelli A, Svelto M, Vescovi AL, et al. (2019) Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats. Cell Death Dis 10:345.","DOI":"10.1038\/s41419-019-1582-5"},{"key":"key-10.4103\/1673-5374.332123-90","doi-asserted-by":"crossref","unstructured":"Zhao W, Beers DR, Appel SH (2013) Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol 8:888-899.","DOI":"10.1007\/s11481-013-9489-x"},{"key":"key-10.4103\/1673-5374.332123-91","doi-asserted-by":"crossref","unstructured":"Zhu Q, Lu P (2020) Stem cell transplantation for amyotrophic lateral sclerosis. Adv Exp Med Biol 1266:71-97.","DOI":"10.1007\/978-981-15-4370-8_6"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:24:43Z","timestamp":1787163883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.332123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":91,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"alternative-id":["332123"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.332123","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}